145 related articles for article (PubMed ID: 23773369)
1. Drug-eluting stents versus bare-metal stents in patients with decreased GFR: a meta-analysis.
Wang ZJ; Harjai KJ; Shenoy C; Gao F; Shi DM; Liu YY; Zhao YX; Zhou YJ
Am J Kidney Dis; 2013 Oct; 62(4):711-21. PubMed ID: 23773369
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of long-term outcomes for drug-eluting stents versus bare-metal stents in primary percutaneous coronary interventions for ST-segment elevation myocardial infarction.
Wallace EL; Abdel-Latif A; Charnigo R; Moliterno DJ; Brodie B; Matnani R; Ziada KM
Am J Cardiol; 2012 Apr; 109(7):932-40. PubMed ID: 22221949
[TBL] [Abstract][Full Text] [Related]
3. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis.
Lu R; Tang F; Zhang Y; Zhu X; Zhu S; Wang G; Jiang Y; Fan Z
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821401
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Drug-Eluting Stents Optimized for Biocompatibility vs Bare-Metal Stents With a Single Month of Dual Antiplatelet Therapy: A Meta-analysis.
Shah R; Rao SV; Latham SB; Kandzari DE
JAMA Cardiol; 2018 Nov; 3(11):1050-1059. PubMed ID: 30383145
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive meta-analysis of randomized controlled trials comparing drug-eluting stents with bare-metal stents in saphenous vein graft interventions.
Shah R; Jovin IS; Latham SB; Hesterberg K; Heckle MR; Rashid A; Vetrovec GW
Catheter Cardiovasc Interv; 2018 Dec; 92(7):1229-1236. PubMed ID: 30051628
[TBL] [Abstract][Full Text] [Related]
7. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction.
Jensen LO; Maeng M; Thayssen P; Kaltoft A; Tilsted HH; Bøttcher M; Lassen JF; Hansen KN; Krusell LR; Rasmussen K; Pedersen KE; Pedersen L; Paaske Johnsen S; Sørensen HT; Thuesen L
Circ Cardiovasc Interv; 2008 Dec; 1(3):176-84. PubMed ID: 20031676
[TBL] [Abstract][Full Text] [Related]
9. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
[TBL] [Abstract][Full Text] [Related]
10. Comparison of outcomes for patients receiving drug-eluting versus bare metal stents for non-ST-segment elevation myocardial infarction.
Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; Fergus I; King SB
Am J Cardiol; 2011 May; 107(9):1311-8. PubMed ID: 21497210
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis comparison (nine trials) of outcomes with drug-eluting stents versus bare metal stents in patients with diabetes mellitus.
Patti G; Nusca A; Di Sciascio G
Am J Cardiol; 2008 Nov; 102(10):1328-34. PubMed ID: 18993150
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
[TBL] [Abstract][Full Text] [Related]
13. Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
Bangalore S; Amoroso N; Fusaro M; Kumar S; Feit F
Circ Cardiovasc Interv; 2013 Aug; 6(4):378-90. PubMed ID: 23922145
[TBL] [Abstract][Full Text] [Related]
14. Very late stent thrombosis with second generation drug eluting stents compared to bare metal stents: Network meta-analysis of randomized primary percutaneous coronary intervention trials.
Philip F; Stewart S; Southard JA
Catheter Cardiovasc Interv; 2016 Jul; 88(1):38-48. PubMed ID: 26916633
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
De Luca G; Dirksen MT; Spaulding C; Kelbaek H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Díaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Cortese G; Suryapranata H; Stone GW;
Arch Intern Med; 2012 Apr; 172(8):611-21; discussion 621-2. PubMed ID: 22529227
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.
Iijima R; Byrne RA; Dibra A; Ndrepepa G; Spaulding C; Laarman GJ; Menichelli M; Valgimigli M; Di Lorenzo E; Kaiser C; Tierala I; Mehilli J; Suttorp MJ; Violini R; Schömig A; Kastrati A
Rev Esp Cardiol; 2009 Apr; 62(4):354-64. PubMed ID: 19401120
[TBL] [Abstract][Full Text] [Related]
17. The EXAMINATION trial (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction): 2-year results from a multicenter randomized controlled trial.
Sabaté M; Brugaletta S; Cequier A; Iñiguez A; Serra A; Hernádez-Antolín R; Mainar V; Valgimigli M; Tespili M; den Heijer P; Bethencourt A; Vázquez N; Backx B; Serruys PW
JACC Cardiovasc Interv; 2014 Jan; 7(1):64-71. PubMed ID: 24332423
[TBL] [Abstract][Full Text] [Related]
18. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis.
Palmerini T; Benedetto U; Biondi-Zoccai G; Della Riva D; Bacchi-Reggiani L; Smits PC; Vlachojannis GJ; Jensen LO; Christiansen EH; Berencsi K; Valgimigli M; Orlandi C; Petrou M; Rapezzi C; Stone GW
J Am Coll Cardiol; 2015 Jun; 65(23):2496-507. PubMed ID: 26065988
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
